Cargando…
Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid
Our early study has found valproic acid (VPA)‐induced lipid dysmetabolism in animal model, however, the details of lipid profiling of VPA‐treated epileptic patients remain unknown. Therefore, in this study, the blood samples of VPA‐treated epileptic patients and VPA‐free controls were collected for...
Autores principales: | Li, Rong, Qin, Xingyue, Liang, Xiaoliu, Liu, Meizhen, Zhang, Xiaoxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714506/ https://www.ncbi.nlm.nih.gov/pubmed/31162795 http://dx.doi.org/10.1111/jcmm.14464 |
Ejemplares similares
-
Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
por: Chung, S., et al.
Publicado: (1997) -
The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
por: Ata Yaseen Abdulqader, Yussra, et al.
Publicado: (2021) -
Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report
por: Praticò, Andrea Domenico, et al.
Publicado: (2009) -
The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury
por: Ma, Yiyi, et al.
Publicado: (2022) -
Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
por: Xu, Shansen, et al.
Publicado: (2019)